Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA.
Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA; University of Central Florida College of Medicine, Orlando, FL, USA.
Int J Pediatr Otorhinolaryngol. 2020 May;132:109919. doi: 10.1016/j.ijporl.2020.109919. Epub 2020 Feb 1.
Endoscopic endonasal skull base surgery (ESBS) is a well-established management strategy for anterior cranial fossa (ACF) encephaloceles in adults. However, its application to the pediatric population has not been evaluated in large-scale studies. This study systematically reviews the safety of ESBS for pediatric ACF encephaloceles.
Articles reporting on pediatric patients undergoing purely ESBS for encephaloceles were reviewed from three databases (PubMed, Scopus, and Cochrane Library). Main outcomes were post-operative cerebrospinal fluid (CSF) leak and other surgical complications.
Twenty-three articles provided data on 110 eligible patients with a mean age of 4.3 years (range birth - 18 years). Intraoperative CSF leaks occurred in 18.5% of children while post-operative CSF leaks developed in 6.0% of cases. Rates of meningitis and hydrocephalus were each 3.7%. Other complications included alar collapse, nasal stenosis, transient diabetes insipidus, pneumonia, and neurologic injury, collectively occurring in 7.0% of cases. The rate of death was 4.8%. The average duration of follow-up was 25.3 months. Encephaloceles recurred in 5.2% of patients.
ESBS for pediatric ACF encephaloceles provides a relatively favorable risk-benefit profile, with a low rate of post-operative CSF leak, other surgical complications, and disease recurrence.
内镜经鼻颅底手术(ESBS)是成人前颅窝(ACF)脑膨出的一种成熟的治疗策略。然而,其在儿科人群中的应用尚未在大规模研究中进行评估。本研究系统地评估了 ESBS 治疗小儿 ACF 脑膨出的安全性。
从三个数据库(PubMed、Scopus 和 Cochrane Library)中回顾了报道小儿患者单纯接受 ESBS 治疗脑膨出的文章。主要结局为术后脑脊液(CSF)漏和其他手术并发症。
23 篇文章提供了 110 名符合条件的患儿数据,平均年龄为 4.3 岁(范围为出生至 18 岁)。术中 CSF 漏发生在 18.5%的患儿中,术后 CSF 漏发生在 6.0%的病例中。脑膜炎和脑积水的发生率分别为 3.7%。其他并发症包括翼塌、鼻狭窄、短暂性尿崩症、肺炎和神经损伤,总发生率为 7.0%。死亡率为 4.8%。平均随访时间为 25.3 个月。5.2%的患者出现脑膨出复发。
ESBS 治疗小儿 ACF 脑膨出具有相对较好的风险效益比,术后 CSF 漏、其他手术并发症和疾病复发的发生率较低。